Target intelligence / Profile preview

Allergen-specific immune tolerance induction

Molecular classification
Other (Therapeutic process/mechanism), Involves regulatory T cells (Tregs), particularly Foxp3^+^ CD4^+^CD25^+^ T cells[1][3], Involves tolerogenic dendritic cells[2][4], Involves cytokines (IL-10, TGF-β, IL-35)[1][3][4], Involves immunoglobulins (IgG4, IgG1)[1][3]
01

Overview

Allergen-specific immune tolerance induction is a therapeutic immunological process used primarily to treat allergic diseases (such as allergic rhinitis, asthma, and food allergy)[1][3][5]. The process is achieved through repeated administration of small, controlled doses of allergen, leading to the expansion of regulatory T cells (particularly Foxp3^+^ CD4^+^CD25^+^ Treg cells) and the production of regulatory cytokines (IL-10, TGF-β). These mediators suppress the function of allergen-specific effector T cells, reduce production of IgE (the key antibody in allergic reactions), and promote the generation of "blocking" IgG4 antibodies that compete with IgE for allergen binding, thus inhibiting mast cell and basophil activation. Tolerogenic dendritic cells also play an important role in driving Treg expansion and differentiation. Effective induction of immune tolerance is measured by increased IgG4, decreased IgE, increased regulatory cell populations, and reduced allergic inflammation[1][3][2][4][5]. This target name refers to a mechanism rather than a druggable molecular entity; any pharmacological intervention aiming to induce allergen-specific tolerance will typically involve multiple molecular and cellular pathways. Therefore, "Allergen-specific immune tolerance induction" is not a canonical drug target but describes a complex multi-component therapeutic outcome[1][3].

Other names
Allergen-specific immunological tolerance inductionAllergen-specific immune toleranceInduction of allergen-specific tolerance
02

Mechanism of action

Expansion and activation of regulatory T cells (Tregs); Induction of tolerogenic dendritic cells[2][4]; Increased secretion of regulatory cytokines (IL-10, TGF-β, IL-35)[1][3][4]; Suppression of allergen-specific Th2 and Th1 effector cells[1][3]; Blockade of mast cell, eosinophil, and basophil activation[1]; Induction of "blocking" IgG4 antibodies that prevent allergen-IgE mediated activation[1][3]; Promotion of T cell anergy and deletion of autoreactive T cells[2][4]

03

Biological functions

Immune response modulationInduction of immune toleranceSuppression of allergic inflammationInhibition of effector T cell migration and activationInduction and maintenance of regulatory T cells[1][3][5]Suppression of IgE production and induction of IgG4[1][3]
04

Disease associations

Allergy (including allergic rhinitis, asthma, food allergy)Inflammation (as related to allergy)Potentially autoimmunity (by similar mechanisms)Other (e.g. tolerance induction in transplantation, not allergen-specific)
05

Safety considerations

Risk of systemic allergic reactions during induction, especially with high dose or rapid escalation protocols[1]Possibility of treatment failure in some individuals due to insufficient tolerance inductionLong duration required for stable immune tolerancePotential for off-target immune modulation with broad tolerance induction regimens
06

Interacting drugs

Allergen extracts (for subcutaneous or sublingual immunotherapy)[1][3]

2 more in the full profile.

07

Biomarkers

Increased levels of allergen-specific IgG4 (and IgG1)[1][3]Reduced levels of allergen-specific IgE[1][3]Increased Foxp3^+^ Tregs (in blood or tissue)[1][3]Increased IL-10 and TGF-β (in serum or in immune cell assays)[1][3]Decreased proliferation or cytokine production in response to allergen challenge[1][3]

Beyond the preview

Go deeper on Allergen-specific immune tolerance induction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allergen-specific immune tolerance induction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call